Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
医学
卵巢癌
肿瘤科
内科学
妇科
癌症
作者
Giorgio Valabrega,Bhavana Pothuri,Ana Oaknin,Whitney S. Graybill,Ana Beatriz Sánchez,Colleen McCormick,Jean‐François Baurain,Anna V. Tinker,Hannelore Denys,Roisin E. O’Cearbhaill,Sakari Hietanen,Richard G. Moore,Anja Ør Knudsen,Thibault de La Motte Rouge,Florian Heitz,Tally Levy,Whitney York,Divya Gupta,Bradley J. Monk,Antonio González‐Martín
To evaluate the impact of age on the efficacy and safety of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer with a complete/partial response to first-line platinum-based chemotherapy.
PDF的下载单位、IP信息已删除
(2025-6-4)
科研通AI6.2
Criminology34
ceeray23
lizishu
MM
嘿嘿
稳重的蛟凤
机灵柚子
Mic
Twonej
bravo
无极微光
Ping
GingerF
殷勤的紫槐
舒心的雍
魏青瑜
fengxiaochao
Wind
全方位小白
科研狗
罗赛
maox1aoxin
wbqdssl
皖公网安备34019202002308
